Spots Global Cancer Trial Database for breast
Every month we try and update this database with for breast cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Preoperative Localisation of the Sentinel Lymph Node in Breast Cancer | NCT01154972 | Breast Cancer | Preoperative se... | - | NHS Tayside | |
| Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients | NCT04300790 | Breast Cancer | Alpelisib Metformin Fulvestrant Letrozole Exemestane Vildagliptin Tamoxifen | 18 Years - | MedSIR | |
| Phase II Trial for Large ER-Negative Breast Cancers | NCT01869192 | Malignant Neopl... | Epirubicin Cyclophosphamid... Docetaxel Capecitabine Radiation Thera... | 18 Years - | University of Colorado, Denver | |
| Phase II Study of Ixabepilone in Metastatic Breast Cancer and Its Effects on the Ultrastructure of Neurons | NCT00627978 | Metastatic Brea... | ixabepilone | 18 Years - | Weill Medical College of Cornell University | |
| Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer Risk | NCT00735150 | Breast Cancer Ovarian Cancer | questionnaire, ... | 18 Years - 39 Years | Memorial Sloan Kettering Cancer Center | |
| Ultrasound Elastography of Breast Lesions | NCT00716482 | Breast Neoplasm... | 21 Years - | SuperSonic Imagine | ||
| Paravertebral Block (PVC) Versus Pectoral Nerve Block (PEC) | NCT03152929 | Breast Cancer | Paravertebral B... Pectoral Nerve ... | 18 Years - | Spectrum Health Hospitals | |
| Trial of Fulvestrant, MK-0646, and Dasatinib for Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer | NCT00903006 | Breast Cancer | Fulvestrant MK-0646 Dasatinib | 18 Years - | M.D. Anderson Cancer Center | |
| Anti-PD-1 Monoclonal Antibody in Advanced, Trastuzumab-resistant, HER2-positive Breast Cancer | NCT02129556 | Metastatic Brea... | MK-3475 | 18 Years - | ETOP IBCSG Partners Foundation | |
| CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448) | NCT02580448 | Cancer of the B... Breast Cancer Advanced Breast... Metastatic Brea... Male Breast Can... Triple Negative... ER+ Breast Canc... | Seviteronel | 18 Years - | Innocrin Pharmaceutical | |
| Randomized Study Versus Placebo for the Prevention of Neurotoxicity Induced by Weekly PACLITAXEL | NCT05695313 | Breast Cancer | OnLife® Placebo | 18 Months - | Centre Georges Francois Leclerc | |
| Sentinel Lymph Node Biopsy With Hybrid Technique in Breast Cancer | NCT04274946 | Breast Cancer | Sentinel lymph ... | 18 Years - 90 Years | Bulent Ecevit University | |
| Case Collection Study to Determine the Accuracy, Call Back and Cancer Detection Rates of QT Ultrasound in Breast Imaging | NCT03052166 | Breast | QT Ultrasound s... | 18 Years - | QT Ultrasound LLC | |
| A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors | NCT02605083 | Cancer | eFT508 | 18 Years - | Effector Therapeutics | |
| Digital Breast Tomosynthesis Preference Study | NCT00776126 | Breast Cancer | Digital Breast ... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies | NCT04503265 | Advanced Malign... Breast Cancer Ovarian Cancer Homologous Reco... Prostate Cancer Pancreatic Canc... | AMXI-5001:Dose ... AMXI-5001:Dose ... | 18 Years - | AtlasMedx, Incorporated | |
| Exploratory Study of Topical Norepinephrine in Breast Cancer Patients Receiving Radiotherapy | NCT01544504 | Radiodermatitis | Norepinephrine | 18 Years - | ProCertus BioPharm, Inc | |
| Post Market Study Using the Xoft Axxent System | NCT01017549 | Breast Cancer | Electronic brac... | 50 Years - | Xoft, Inc. | |
| Low Dose Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts | NCT01925170 | Breast Cancer | Molecular Breas... Conventional Ma... Technetium (99m... | 40 Years - | Mayo Clinic | |
| An Innovation During the Surgical Wait; Evaluation of the Opportunity for Intervention | NCT02261311 | Breast Cancer | Quality of Life | 19 Years - | Ottawa Hospital Research Institute | |
| Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast Cancer | NCT03703557 | Breast Cancer Surgery | Sorbstar® Odour sampling | 18 Years - | Institut Curie | |
| The Biology of Claudin 3 in Primary Human Mammary Epithelial Cell Culture | NCT00481585 | Breast Cancer | - | Hackensack Meridian Health | ||
| Quantitative Dynamic Contrast Enhanced Breast MRI | NCT00582764 | Breast Cancer | perform dynamic... | - | Memorial Sloan Kettering Cancer Center | |
| Quadrant High Dose Rate Intraoperative Radiation Therapy (IORT) for Early-Stage Breast Cancer: A Pilot Study | NCT00595062 | Breast Cancer | Intra Operative... | 60 Years - | Memorial Sloan Kettering Cancer Center | |
| Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel | NCT00039780 | Breast Neoplasm... Breast Diseases Metastases, Neo... | BNP7787 Placebo | 18 Years - | BioNumerik Pharmaceuticals, Inc. | |
| Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine) | NCT04341129 | Breast Neoplasm... Breast Diseases Breast Fibroade... Breast Cancer | Abbreviated MRI... | 18 Years - 80 Years | University of Chicago | |
| Test of Digital Breast Tomosynthesis vs. Regular Mammography in Detecting Breast Cancer in Women Undergoing Diagnostic Mammography | NCT00535327 | Breast Cancer | 18 Years - | GE Healthcare | ||
| Tenovus Cancer Choirs Study: the Benefits of Singing for Those Affected by Cancer | NCT02756780 | Cancer | Tenovus Cancer ... | 18 Years - | Royal Marsden NHS Foundation Trust | |
| Patterns of Treatment and Outcome of Palbociclib Plus Endocrine Therapy | NCT04524728 | Breast Neoplasm Malign... Female | Palbociclib Letrozole 2.5mg Fulvestrant | 18 Years - | Istituti Clinici Scientifici Maugeri SpA | |
| Evaluation of the Safety and Tolerability of Niraparib With Everolimus in Advanced Gynecologic Malignancies and Breast | NCT03154281 | Breast Cancer Ovarian Cancer | niraparib everolimus | 18 Years - | Avera McKennan Hospital & University Health Center | |
| Exploratory Study of Topical Norepinephrine in Breast Cancer Patients Receiving Radiotherapy | NCT01544504 | Radiodermatitis | Norepinephrine | 18 Years - | ProCertus BioPharm, Inc | |
| Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients | NCT00206492 | Breast Cancer | Iressa Tamoxifen | 18 Years - | Baylor Breast Care Center | |
| I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer | NCT01042379 | Breast Neoplasm... Breast Cancer Breast Tumors Angiosarcoma TNBC - Triple-N... HER2-positive B... HER2-negative B... Hormone Recepto... Hormone Recepto... Early-stage Bre... Locally Advance... | Standard Therap... AMG 386 with or... AMG 479 (Ganitu... MK-2206 with or... AMG 386 and Tra... T-DM1 and Pertu... Pertuzumab and ... Ganetespib ABT-888 Neratinib PLX3397 Pembrolizumab -... Talazoparib plu... Patritumab and ... Pembrolizumab -... SGN-LIV1A Durvalumab plus... SD-101 + Pembro... Tucatinib plus ... Cemiplimab Cemiplimab plus... Trilaciclib wit... SYD985 ([vic-]t... Oral Paclitaxel... Oral Paclitaxel... Amcenestrant Amcenestrant + ... Amcenestrant + ... ARX788 ARX788 + Cemipl... VV1 + Cemiplima... Datopotamab der... Datopotamab der... Zanidatamab Lasofoxifene Z-endoxifen ARV-471 ARV-471 + Letro... | 18 Years - | QuantumLeap Healthcare Collaborative | |
| A Window-of-opportunity Study of Pelareorep in Early Breast Cancer | NCT04102618 | Breast Cancer | Pelareorep Letrozole Atezolizumab Trastuzumab | 18 Years - | Oncolytics Biotech | |
| Neoadjuvant Biomarker ResearcH Study of Palbociclib Combined With Endocrine Therapy in Estrogen Receptor Positive/HER2 Negative Breast CAncer (NeoRHEA) | NCT03065621 | Breast Cancer F... | Palbociclib | 18 Years - | Jules Bordet Institute | |
| Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer | NCT04120246 | Anatomic Stage ... HER2 Positive B... Metastatic Brea... Refractory Brea... | Alpha-tocophery... Trastuzumab | 18 Years - | Veana Therapeutics | |
| Analysis of Data From the Women's Contraceptive and Reproductive Experiences (CARE) Study | NCT00341159 | Breast Cancer | 35 Years - 64 Years | National Institutes of Health Clinical Center (CC) | ||
| Lapatinib and RAD-001 for HER2 Positive Metastatic Breast Cancer | NCT01283789 | Metastatic Brea... | Lapatinib and R... | 18 Years - | University of Kansas Medical Center | |
| Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer | NCT04174742 | Breast | pegfilgrastim | 18 Years - | Wake Forest University Health Sciences | |
| Feasibility Study of Cavity Radiofrequency Ablation in ex Vivo Mastectomy Breast Tissue | NCT02525913 | Breast Cancer | RFA Applicator | 18 Years - | University of Arkansas | |
| Pycnogenol for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors | NCT00064857 | Lymphedema Breast Cancer | Pycnogenol | 18 Years - | National Center for Complementary and Integrative Health (NCCIH) | |
| Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study | NCT02562170 | Breast Cancer Hereditary Brea... | TiLoop Bra Protexa | 18 Years - 75 Years | Medical University of Vienna | |
| Safety and Efficacy of Using CBUS™ System for Ultrasound Breast Imaging Designed for Breast Tumor Diagnosis | NCT00355745 | Breast Cancer | Ultrasound brea... | 21 Years - 70 Years | Helix Medical Systems | |
| Patient Factors Impacting Adherence to Oral Chemotherapy | NCT01487343 | Breast Cancer Gastrointestina... | questionnaire a... | 21 Years - | Memorial Sloan Kettering Cancer Center | |
| Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine) | NCT04341129 | Breast Neoplasm... Breast Diseases Breast Fibroade... Breast Cancer | Abbreviated MRI... | 18 Years - 80 Years | University of Chicago | |
| Assessing the Sensitivity of "SureTouch™" in Women Undergoing Diagnostic and Screening Mammography | NCT04397029 | Breast Cancer | SureTouch | 30 Years - 80 Years | George Washington University | |
| Impact of Dietary Intervention on Tumor Immunity: the DigesT Trial | NCT03454282 | Breast Cancer Melanoma, Malig... | FMD | 18 Years - 75 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers | NCT02583542 | Triple-Negative... Squamous Cell L... Non-squamous Ce... Non-squamous Ce... | AZD2014 AZD6244 | 18 Years - | Queen Mary University of London | |
| Study Into the Use of Electrical Impedance Mammography in the Diagnosis and Characterisation of Breast Disease | NCT01217489 | Breast Cancer | Breast scan - E... | 18 Years - | Oxford University Hospitals NHS Trust | |
| Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012) | NCT00931606 | Chemotherapy In... | Sotatercept Placebo | 18 Years - | Merck Sharp & Dohme LLC | |
| Intrapleural Bevacizumab After Pleural Drainage in the Context of Breast Cancer | NCT02250118 | Pleural Effusio... Breast Cancer | Bevacizumab | 18 Years - | Institut Curie | |
| Observation of Medical Treatments in MBC HER2-negative Patients | NCT02365831 | Metastatic Brea... | Observation of ... | 18 Years - | Consorzio Oncotech | |
| Oral Health and Oral Health-Related Quality of Life in Early Stage Breast Cancer Survivors | NCT01272570 | Breast Cancer Xerostomia | 50 Years - | University of Michigan | ||
| Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Rlisk | NCT00839696 | Breast Cancer R... | 55 Years - 70 Years | University of Wisconsin, Madison | ||
| Breast Cancers: Risk Factors Among Mexican Women in Mexico, Mexican-American and African-American Women in the U.S. | NCT00837499 | Breast Cancer | Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| Photography or Video in Assessing Breast Reconstruction? | NCT01547338 | Breast Neoplasm... Breast Reconstr... | 18 Years - | NHS Greater Glasgow and Clyde | ||
| Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy | NCT02012608 | Breast Cancer | Glutamine Placebo | 18 Years - | University of Arkansas | |
| Trial of Fulvestrant, MK-0646, and Dasatinib for Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer | NCT00903006 | Breast Cancer | Fulvestrant MK-0646 Dasatinib | 18 Years - | M.D. Anderson Cancer Center | |
| Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts | NCT00620373 | Breast Cancer | Molecular Breas... Conventional Ma... Technetium (99m... | 25 Years - | Mayo Clinic | |
| A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study | NCT04215146 | Breast Cancer M... | Paclitaxel Pelareorep Avelumab | 18 Years - | Oncolytics Biotech | |
| Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers | NCT00608452 | Lung Cancer Ovarian Cancer Breast Cancer Hodgkin's Disea... Neuroblastoma | Symptom Assessm... | - | Memorial Sloan Kettering Cancer Center | |
| A Clinical Study to Evaluate Somo•v and Digital Mammography Together as a Breast Cancer Screening Method, Compared to Digital Mammography Alone, in Women With Dense Breasts. | NCT00816530 | Breast Cancer | Automated Breas... | 25 Years - | U-Systems, Inc. | |
| Brachytherapy Radiation Directly to the Liver in Breast Cancer Patients With Metastatic to Liver | NCT00891800 | Breast Cancer M... | Brachytherapy SIR-Sphere | 18 Years - 85 Years | St. Joseph's Hospital, Florida | |
| XRP9881 in Combination With Trastuzumab in Metastatic Breast Cancer | NCT00386685 | Breast Neoplasm... | larotaxel (XRP9... trastuzumab | 18 Years - | Sanofi | |
| Using Bio Markers to Predict Disease Recurrence and Cognitive Function in High Risk Breast Ca | NCT00756132 | Locally Advance... Breast Cancer | 18 Years - 65 Years | University Health Network, Toronto | ||
| Impact of Osteopathy on Pain After Breast Cancer Surgery | NCT02621437 | Breast Cancer | Osteopathy sess... phone questionn... | 18 Years - | Hospices Civils de Lyon | |
| Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast Cancer | NCT00206453 | Breast Cancer | Taxotere | 18 Years - | Baylor Breast Care Center | |
| The Role of Calcipotriol as Radioprotector of Skin | NCT00445250 | Radiodermatitis | Calcipotriol | 18 Years - 75 Years | Rabin Medical Center | |
| Description of the Analgesia Obtained With the Anesthesiological Protocols Currently Used in Breast Surgery | NCT04309929 | Breast Cancer | Analgesics | 18 Years - | Careggi Hospital | |
| Breast Cancer Molecular Analysis Protocol | NCT01855503 | Metastatic Brea... | Core Biopsy | - | Yale University | |
| Pilot Study Evaluating the Oncogramme: Analysis of Response to Induction Treatment of Patients With Breast or Ovarian Cancer. | NCT02910622 | Breast Cancer Ovarian Cancer | Chimio-oncogram... | 18 Years - | University Hospital, Limoges | |
| Evaluate the Use of the Magnetic Resonance Spectroscopy in Determining if the Breast Tumor is Benign or Malignant | NCT00639171 | Breast Tumors | 18 Years - 70 Years | State University of New York - Upstate Medical University | ||
| Post-operative Radiation With IMRT in the Management of Stage IIB-III Breast Cancer | NCT00508352 | Breast Cancer | Helical tomothe... | 18 Years - | Ottawa Hospital Research Institute | |
| Sonographic Visibility of Breast Biopsy Marker Clips Up to 4 Weeks After Placement | NCT00548392 | Breast Cancer | 18 Years - | Fred Hutchinson Cancer Center | ||
| Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012) | NCT00931606 | Chemotherapy In... | Sotatercept Placebo | 18 Years - | Merck Sharp & Dohme LLC | |
| Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Rlisk | NCT00839696 | Breast Cancer R... | 55 Years - 70 Years | University of Wisconsin, Madison | ||
| Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and Older | NCT00741039 | Breast Cancer Lung Cancer Prostate Cancer | inactivated inf... inactivated inf... | 65 Years - | Memorial Sloan Kettering Cancer Center | |
| INST 0514C- Biologic Correlative Study: Trial of GW572016 in HER2 Overexpressing Breast Cancer Patients | NCT00455039 | Breast Cancer | GW572016 | - | University of New Mexico | |
| Fulvestrant in Postmenopausal Patients With Metastatic Breast Cancer | NCT01399086 | Breast Cancer | Fulvestrant | 18 Years - | Hellenic Oncology Research Group | |
| Multi-scale Modeling of Breast Conserving Therapy | NCT02310711 | Breast Cancer | Standard of Car... | 30 Years - 80 Years | The Methodist Hospital Research Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
